Myopia And Presbyopia Treatment Market | USD 47.77 Billion by 2034
The global myopia and presbyopia treatment market was valued at USD 20.36 billion in 2024 and is projected to reach USD 47.77 billion by 2034, registering a CAGR of 8.9% from 2025 to 2034. The global myopia and presbyopia treatment market growth is attributed to the increasing incidence of distance vision impairment due to uncorrected myopia.
The U.S. myopia and presbyopia treatment market size was valued at USD 4.31 billion in 2024 and is expected to reach around USD 9.21 billion by 2034, growing at a CAGR of 7.9% from 2025 to 2034.
Asia Pacific dominated the myopia and presbyopia treatment market in 2024. The market growth in the region is attributed to the increasing presence of a large number of market players and the availability of advanced technologies for treating the targeted myopia treatment types. China, India, Japan and South Korea are the dominating countries driving the market growth. Vision issues such as myopia and presbyopia are among the most common refractive errors in India. There are the most appropriate treatment options available in India, which further drives the market growth.
Market Trends in North America
The market growth in the region is driven by factors such as the rising disposable income of consumers and growing medical tourism. In addition, the increasing prevalence of eye-related myopia treatment types and the increasing geriatric population are further expected to drive the growth of the myopia and presbyopia treatment market. The U.S. and Canada are the fastest growing countries in the region. The market is witnessing major growth in the U.S. due to the increasing number of ongoing studies and the introduction of advanced lenses such as implantable contact lenses and intraocular phakic presbyopic lenses.
The myopia and presbyopia treatment market is experiencing significant growth at a healthy rate, which is majorly related to the rapid growth in the geriatric population across the globe and the increasing number of people with vision impairment. The rates of myopia are increasing, particularly among adolescents and children, and have become a major concern due to dramatic lifestyle changes, increased screen time, and urbanization. In addition, as more aging people are looking for solutions to their age-related vision problems, the rapidly growing demographic structure is also raising the demand for presbyopia treatments.
The increasing prevalence of presbyopia across the globe, increasing widespread adoption of telemedicine, and increasing introduction of advanced lenses such as implantable contact lenses and intraocular phakic presbyopic lenses are further expected to drive the growth of the myopia and presbyopia treatment market during the forecast period.
| Report Coverage | Details |
| Market Size in 2025 | USD 22.18 Billion |
| Market Size by 2034 | USD 47.77 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 8.9% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Type, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | Ziemer Ophthalmic Systems AG; NIDEK CO. LTD.; Johnson & Johnson Vision; Essilor Ltd.; Zeiss International; ALCON VISION LLC; Bausch & Lomb Incorporated; Haag-Streit UK; Topcon Corporation. |
Technological advancements in treatment methods create market opportunities
The rising innovations such as new pharmacological treatments, advanced intraocular lenses, and laser surgeries are enhancing the safety and efficacy of interventions. These advancements foster higher patient acceptance and improve patient outcomes for various treatments. In addition, rising research and development activities in vision correction technology are further anticipated to enhance more effective additives for managing presbyopia and myopia in the coming years, contributing to the myopia and presbyopia treatment market.
Resistance to surgery may hamper market growth
When it comes to eyes, many people are apprehensive and afraid about undergoing surgical procedures. Concerns about potential side effects, complications, and pain can reduce patients from considering surgery as a treatment option. Patients often prefer minimally invasive or non-invasive treatment options over surgery. Some treatments may face challenges or delays in gaining regulatory approval, which is further expected to restrain the growth of the myopia and presbyopia treatment market
The single prescription lenses segment dominated the myopia and presbyopia treatment market. The segment growth in the market is driven by factors such as increasing demand for corrective lenses, growing patient pool, and increasing prevalence of myopia in emerging countries. Whereas the contact lenses segment is expected to grow fastest during the forecast period. The segment is witnessing significant growth due to the decreasing service costs, increasing availability of advanced equipment, and rising technologically advanced solutions.
The prescription lens dominated the myopia and presbyopia treatment market. The increasing demand for LASIK surgery and the high prevalence of myopia treatment types are expected to drive the segment growth. In addition, the progressive multifocals segment is expected to grow fastest during the forecast period. The segment growth in the market is attributed to the rising innovations in multifocals, such as photochromic lenses and multifocals incorporated with anti-reflexive coating, and increasing preference for correcting presbyopia. Due to the visual and aesthetic advantages, they are commonly accepted, which is further expected to drive the segment growth.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the myopia and presbyopia treatment market
By Myopia Treatment Type
By Presbyopia Treatment Type
By Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers